CAS Medical Systems (NASDAQ:CASM) was downgraded by stock analysts at Craig Hallum from a “buy” rating to a “hold” rating in a research note issued on Tuesday, The Fly reports.
CAS Medical Systems stock traded up $0.84 during mid-day trading on Tuesday, hitting $2.41. The company had a trading volume of 299,087 shares, compared to its average volume of 42,839. CAS Medical Systems has a 12-month low of $0.99 and a 12-month high of $2.70. The firm has a market cap of $45.80 million, a PE ratio of -8.96 and a beta of 0.45.
A number of institutional investors have recently added to or reduced their stakes in the business. Douglas Lane & Associates LLC purchased a new stake in CAS Medical Systems in the 4th quarter worth approximately $54,000. Vanguard Group Inc lifted its position in shares of CAS Medical Systems by 2.8% during the 3rd quarter. Vanguard Group Inc now owns 547,560 shares of the medical technology company’s stock valued at $1,249,000 after buying an additional 15,155 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of CAS Medical Systems by 76.4% during the 3rd quarter. Renaissance Technologies LLC now owns 682,017 shares of the medical technology company’s stock valued at $1,555,000 after buying an additional 295,478 shares in the last quarter. Ingalls & Snyder LLC purchased a new position in shares of CAS Medical Systems during the 3rd quarter valued at approximately $1,142,000. Finally, BlackRock Inc. lifted its position in shares of CAS Medical Systems by 569.2% during the 2nd quarter. BlackRock Inc. now owns 84,091 shares of the medical technology company’s stock valued at $164,000 after buying an additional 71,525 shares in the last quarter. Institutional investors and hedge funds own 27.92% of the company’s stock.
CAS Medical Systems, Inc, a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations.
Recommended Story: What does relative strength index mean?
Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.